Visual snow …

Headache & Pain

Updated 01.15.2024
Released 12.27.2019
Expires For CME 01.15.2027

Visual snow

Authors: Peter J Goadsby MD PhD FRS, Francesca Puledda MD

See Contributor Disclosures

Editor: Stephen D Silberstein MD

Visual snow

In This Article

Quick Link

Introduction

Overview

Visual snow is a neurologic condition that was first systematically and clinically defined in 2014. The main clinical feature is that of an unremitting, positive visual phenomenon present in the entire visual field and characterized by uncountable tiny flickering dots. In addition to this “static” phenomenon, patients with visual snow can experience visual symptoms of either direct neurologic origin, such as palinopsia, photophobia, and impaired night vision, or that arise from the optic apparatus, such as the entoptic phenomena. Different combinations of these additional symptoms, together with the static itself, constitute visual snow syndrome. In the past few years, recognition of visual snow syndrome has grown considerably in both clinical neurology and neuroscience, and the medical literature on the topic has increased. Nonetheless, the pathophysiology, causes, and treatment of visual snow remain largely unknown.

Key points

	• Visual snow is a neurologic disorder chiefly characterized by visual static, resembling a detuned television.
	• The visual snow syndrome is characterized by visual snow plus other distracting visual symptoms such as palinopsia, entoptic phenomena, nyctalopia, and photophobia.
	• Although progress has been made, the pathophysiology of visual snow is not well understood, and there are no clearly established treatments.
	• The most frequent comorbidities of visual snow are migraine and tinnitus.
	• Visual snow should be clinically differentiated from prolonged migraine aura and hallucinogen persisting perception disorder.

Historical note and terminology

Early clinical reports of visual snow were described in the context of larger case series of migraine patients and were defined with terms such as: “persistent positive visual phenomena” (28), “persistent positive visual disturbances” (23), or “persistent visual aura without infarction” (58; 10).

The first clear description of visual snow as a unique clinical phenomenon can be found in a case report of a young female patient (47). In this paper, visual snow was also termed “positive persistent visual symptoms”.

A study published the following year provided the first systematic characterization of visual snow, distinguishing it clearly from migraine with and without aura (42). This paper also outlined criteria for visual snow syndrome that are currently in use (Clinical manifestations section).

Clinical manifestations

Presentation and course

The following are the published criteria for the clinical definition of visual snow syndrome (42; 38):

(A) Visual snow: dynamic, continuous, tiny dots in the entire visual field lasting longer than 3 months.
(B) Presence of at least two additional visual symptoms from the four following categories:
	(i) Palinopsia. At least one of the following: afterimages or trailing of moving objects.
	(ii) Enhanced entoptic phenomena. At least one of the following: excessive floaters in both eyes, excessive blue field entoptic phenomenon, self-light of the eye, or spontaneous photopsia.
	(iii) Photophobia
	(iv) Nyctalopia
(C) Symptoms are not consistent with typical migraine visual aura.
As defined by the International Headache Society in the International Classification of Headache Disorders (21).
(D) Symptoms are not better explained by another disorder.
Normal ophthalmology tests (best corrected visual acuity, dilated fundus exam, visual field, and electroretinogram); not caused by previous intake of psychotropic drugs.

The main symptom in visual snow, common to all patients with and without the full syndrome, is the visual static (described in criterion A). The moving dots that constitute the static are typically of black/grey color on a white background and of grey/white color on a black background; they can, however, also be transparent, white flashing, or multicolored. A single patient can present more than one type of static color, with some subjects experiencing all four types in different moments. Of the combinations, black and white static associated with transparent static seems to be the most common (37).

Visual snow example

(Contributed by Dr. Peter Goadsby.)

About three quarters of individuals with visual snow report at least three of four accompanying visual phenomena (criterion B), in addition to the static. These symptoms, that as specified constitute the visual snow syndrome, are: palinopsia, exaggerated entoptic phenomena, photophobia, and nyctalopia.

Palinopsia is a neurologic phenomenon described as the persistence of an image even after the originating stimulus has disappeared from the visual field (11). In visual snow syndrome palinopsia typically manifests as afterimages or as visual trailing. The afterimage of visual snow is different from a typical retinal afterimage that occurs when staring at a high contrast image and is perceived in complementary color (24); this phenomenon can be experienced by healthy individuals.

Entoptic phenomena are symptoms that arise from the optic apparatus and that are often normally perceived in the general population. In visual snow, however, they are present on a daily basis, becoming very debilitating and causing disruption in normal vision. Visual snow entoptic phenomena can include excessive floaters in both eyes, excessive blue field entoptic phenomena (uncountable little grey/white/black dots or rings shooting over the visual field of both eyes when looking at homogeneous bright surfaces such as the blue sky), self-light of the eye (colored waves or clouds perceived when closing the eyes in the dark), and spontaneous photopsia, characterized by bright flashes of light.

Nearly two thirds of individuals with visual snow report light sensitivity. The key characteristic of photophobia is the avoidance of light, which can either be perceived as being too bright (photic hypersensitivity) or in some cases even painful (photic allodynia). Patients with visual snow syndrome can suffer continuously from photophobia and be severely distressed by it (15; 53).

Nyctalopia is defined as a difficulty seeing at night or in the dark and can be a manifestation of severe eye disorders. As with all the other symptoms in visual snow, however, it is present in patients who have normal eye exams (criterion D) and is, therefore, likely due to a central visual processing alteration. It is also possible that the difficulty seeing in the dark in visual snow could be due to an increased prominence of the static when there is less ambient light.

The described additional visual disturbances can present in several combinations within visual snow syndrome; however, floaters, afterimages, and photophobia are almost invariably present and seem to represent a hallmark of the syndrome.

With regards to clinical presentation, the onset of symptoms can be sudden in visual snow in up to one quarter of the cases (32). There have also been reports of visual snow starting out as an episodic ictal disorder and then gradually evolving into a chronic condition (42; 56). The overwhelming majority of patients with visual snow, however, report a gradual onset of symptoms, with up to 40% recalling elements of the condition for as long as they can remember.

Cases of secondary visual snow syndrome have also been reported, eg, following a stroke (09; 45), the start of a new medication (16), a dramatic change in migraine, and a concussion or an infection (30).

Prognosis and complications

A prospective longitudinal study of patients with visual snow syndrome contacted 8 years after initial assessment showed persistence of symptoms in all contacted, noting that 49% of the initial cohort were lost to follow-up (19). Visual snow symptoms themselves had not worsened, consistent with clinical experience that visual snow is likely a nondegenerative disorder. There have been no reported cases of loss of vision following onset of visual snow to date, and generally the condition seems to be stable through time, albeit in some patients with periods of worsening.

There are no clearly determined worsening factors; however, recreational drug use, alcohol intake, migraine attacks, stress, and other illnesses can accentuate symptoms for a short or long period in some patients.

Clinical vignette

A fictitious patient with visual snow is described as follows:

Male patient, aged 24, with a history of episodic migraine without aura and no other prior illnesses, suddenly starts noticing, during a period of intense stress, the presence of a visual disturbance that he describes as “TV-static”. The static is black and white, and sometimes yellow or transparent. It has never gone away since the start and is more noticeable when the lights are off. It is also visible with eyes closed.

During the following days, the patient starts noticing several other symptoms. For example, objects he has just been looking at reappear in his vision once he turns away, strong lights are often surrounded by a glare and flashes, and driving at night is now difficult because he is very bothered by the luminous trails from other car lights. These new visual symptoms are associated with emotional distress and anxiety.

The patient is seen by the local GP and ophthalmologists, who find no signs of ocular disease. Given his history of migraine, the GP suggests drug treatment with propranolol and topiramate, which do not improve his symptoms, and requests a neurologic consult.

Upon taking a medical history, we learn that the patient, a college student, drinks coffee two to three times per day, occasionally drinks alcohol in moderate quantities, and has never been exposed to recreational drugs. His neurologic examination is normal and an MRI with gadolinium shows no brain abnormalities. His episodic migraine has worsened in frequency in the last few months, from a baseline of one attack every 4 to 5 months to two to three attacks per month. His chief and most worrying symptom, however, is the visual static, which has not worsened or improved since the start and is affecting his life and studies. In particular, he is finding it increasingly difficult to read and is quite distressed by the lack of a clinical diagnosis for his condition.

After diagnosing the patient with visual snow syndrome of sudden onset, we review him after a few months. He has noticed no particular change in his visual static; however, he does report that since knowing of the condition – and particularly that no worsening of his eyesight is to be expected – he has been coping much better with the visual snow syndrome symptoms.

Biological basis

The neurobiological mechanisms of visual snow are largely unknown. Neuroimaging and neurophysiological data, however, have shed some light on certain aspects of its pathophysiology.

From a clinical perspective, considering the chief clinical symptom of a whole-field visual disturbance, this is unlikely to be caused by a disorder of the anterior visual pathway, optic radiation, or primary visual cortex, given that these structures are organized in a monocular or homonymous fashion. Further, the additional symptoms of the visual snow syndrome phenotype, such as palinopsia, seem to involve the processing of visual information in the supplementary visual cortex, downstream of the primary visual cortex. Retinal electrophysiology suggests some change in rod and cone photoreceptors may play a role (60).

The possibility of a cortical dysfunction in visual snow is supported by the reports of normal eye examinations and visual evoked potentials in patients with visual snow, as well as the results from brain imaging studies, showing hypermetabolism in the region of the lingual gyrus with [¹⁸F]-FDG PET (43). The lingual gyrus is an area pertaining to the supplementary visual cortex, and which is interestingly also involved in migrainous photophobia. This same region also showed a localized disturbance in anaerobic metabolism in patients with visual snow syndrome compared to healthy controls in a study combining functional MRI and spectroscopy (34).

Cortical hyperactivity was also demonstrated in visual snow via arterial spin-labeled MRI in a study involving 24 patients with visual snow syndrome compared to healthy controls (39). Higher cerebral blood flow was found in patients over an extensive brain network, including visual and motor areas, the cerebellum, and the posterior cingulate cortex. Interestingly, these areas were the same, both when patients were at rest and when visually stimulated, highlighting that the alteration may represent a neurophysiological signature of the condition.

A similar dysfunction of visual processing in areas of the ventral visual stream was found in a patient with visual snow syndrome through [123I]-IMP SPECT, with a distribution matching the ventral visual stream (46).

Further, patients with visual snow exhibit several subtle structural changes in areas that pertain to the visual cortex and extending beyond the visual system as well (32; 43; 31).

Functional brain connectivity studies have shown that patients with visual snow exhibit a dysfunction of the precortical and cortical visual pathways, the visual motion network, the attentional networks, and the salience network (36) as well as a hyperconnectivity between extrastriate visual areas and other temporal brain regions (02). Brain network dynamic studies similarly demonstrate changes in occipital and parietal cortex compared to controls (51).

Further, neurobehavioral studies have demonstrated that patients with visual snow syndrome present coordination changes in the saccadic control system (48; 49; 50; 18), which confirm an alteration of visual processing and may also represent a misallocation of visual attention in affected subjects. A neurobehavioral study also confirms the theory of increased cortical excitability of the visual areas and further attributes it to an increased neural response to external stimuli rather than to an abnormally elevated neural noise (07).

Electrophysiology has shown that visual snow is characterized by a processing disturbance at the level of the secondary visual areas (13) as well as altered habituation at the level of the primary visual cortex (29; 59); however, the latter was not confirmed in a subsequent study (14). Magnetoencephalographic work similarly points to cortical dysfunction (22).

The high comorbidity between visual snow and migraine, as well as tinnitus and hallucinogen perceptual persisting disorder (see Associated disorders section), allows some further insight into the biology of the condition. A dishabituation mechanism similar to what has been described for migraine (12) would explain its high presence in visual snow, even if these are two different conditions. The presence of associated visual symptoms – enhanced entoptic phenomena in particular – also potentially points to a disorder of habituation and sensory processing, which could allow the perception of stimuli that are normally ignored by the brain.

Tinnitus is not only highly comorbid with visual snow but also predicts its severity. On a theoretical basis, visual snow and tinnitus could represent two different manifestations of broadly similar pathophysiology, which is the perception of a sensory stimulus that is not present or is normally subthreshold within the brain.

Finally, hallucinogen perceptual persisting disorder is a condition codified in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (03) and characterized by the reexperiencing of perceptual symptoms (“flashbacks”) typically of visual type that follow the cessation of the use of a hallucinogen and that had been experienced during the intoxication. Occasionally, hallucinogen perceptual persisting disorder can manifest with forms of visual static, palinopsia, and flashes (01; 20). This suggests a possible common basis between the two conditions, possibly mediated by a serotonergic mechanism (16), although it must be stressed that visual snow occurs mostly in patients who have never been exposed to recreational drugs. The finding by Receptor-Enriched Analysis of functional Connectivity by Targets (REACT) that patients with visual snow syndrome have reduced functional connectivity in 5HT-2A enriched networks, largely in occipito-temporo-parietal cortices, further points to the serotoninergic involvement in the syndrome (33).

Interestingly, research has shown that in the presence of hallucinogen perceptual persisting disorder, visual snow syndrome mostly manifests without migraine, suggesting that different pathophysiological factors play a role in the overlap between these three disorders (55).

Etiology and pathogenesis

Validation of a theoretical framework regarding visual snow pathophysiology will require corroboration from experimental research. Nonetheless, some theories have been advanced with regards to the etiology of visual snow. These include: thalamo-cortical dysrhythmia of the visual pathways (27), hyperexcitation of primary and secondary visual cortices (13; 29; 59), increased saliency of normally ignored subcortical activity, or possibly a combination of all of these mechanisms (35).

The results of neuroimaging, neurobehavioral, and neurophysiological studies indicating widespread functional and structural alterations in visual and extravisual areas, together with the typical clinical picture, suggest that visual snow syndrome may represent a complex brain network disorder (25). This would justify an impairment in the filtering of irrelevant internal and external stimuli, ultimately culminating in an ongoing perceptual disorder of vision. High-field 7T MRI demonstrates microstructural changes that are most evident in the occipital cortex and thalamus, without changes in morphometry (52).

It has been reported that patients with visual snow syndrome do not respond to calcitonin gene-related peptide (CGRP) monoclonal antibodies (17).

Remarkably, it has been reported that visual snow can transform from an episodic to a chronic state after cerebellar infarction (41).

Differential diagnosis

Confusing conditions

The main differential diagnosis for visual snow is outlined in the clinical criteria (C and D). It is important to exclude the following conditions in cases of suspected visual snow:

Migraine aura. Atypical visual aura can occur with unusual phenotypes, prolonged duration of symptoms, and in the absence of migrainous pain (44; 04). All these cases can mimic the phenotypical presentation of visual snow and, therefore, need to be considered in the differential diagnosis. Important considerations for the clinician are to determine if there are other concomitant aura symptoms, if there is an underlying migraine biology, and if there are other properties of typical aura phenomenology, such as spreading and location in a visual hemifield.

Ophthalmic disorders. Photopsia, especially when associated with a sudden increase in floaters and when more apparent in the dark, can be the symptom of retinal or vitreal detachment (08). If accompanied by glares, shimmering around objects, visual loss, and night blindness, photopsias can also be caused by both retinal degeneration and paraneoplastic melanoma-associated retinopathy syndromes. The keys to not missing the above diagnoses are a good ophthalmologic examination, including acuity, visual fields when appropriate, and a dilated fundus examination. An electroretinogram is useful when the diagnosis remains unclear (06) (see Diagnostic workup section).

Hallucinogen perceptual persisting disorder. As explained in the Biological basis section, hallucinogen perceptual persisting disorder can present with visual static, palinopsia, and flashes. Therefore, appropriate history taking needs to include an inquiry on recent use of hallucinogenics.

References

01: Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry 1983;40(8):884-9. PMID 6135405
02: Aldusary N, Traber GL, Freund P, et al. Abnormal connectivity and brain structure in patients with visual snow. Front Hum Neuroscience 2020;14:582031. PMID 33328934
03: American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington VA, 2013.
04: Barral E, Martins Silva E, Garcia-Azorin D, Viana M, Puledda F. Differential diagnosis of visual phenomena associated with migraine: spotlight on aura and visual snow syndrome. Diagnostics (Basel) 2023;13(2):252. PMID 36673062
05: Berkowitz E, River Y, Digre K, Tiosano B, Kesler A. Visual snow: a case series from Israel. Case Rep Ophthalmol 2020;11(2):205-11. PMID 32595484
06: Braithwaite T, Holder GE, Lee RW, Plant GT, Tufail A. Diagnostic features of the autoimmune retinopathies. Autoimmun Rev 2014;13(4-5):534-8. PMID 24424196
07: Brooks CJ, Chan YM, Fielding J, White OB, Badcock DR, McKendrick AM. Visual contrast perception in visual snow syndrome reveals abnormal neural gain but not neural noise. Brain 2022;145(4):1486-98. PMID 34633444
08: Brown GC, Brown MM, Fischer DH. Photopsias: a key to diagnosis. Ophthalmology 2015;122(10):2084-94. PMID 26249730
09: Catarci T. Occipital ischaemic stroke after visual snow phenomenon - a case report. Cephalalgia 2021;41(7):871-4. PMID 33435707
10: Chen WT, Lin YY, Fuh JL, Hamalainen MS, Ko YC, Wang SJ. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain 2011;134:2387-95. PMID 21729907
11: Critchley M. Types of visual perseveration: "paliopsia" and "illusory visual spread". Brain 1951;74(3):267-99. PMID 14869536
12: Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia 2007;27(12):1427-39. PMID 18034686
13: Eren O, Rauschel V, Ruscheweyh R, Straube A, Schankin CJ. Evidence of dysfunction in the visual association cortex in visual snow syndrome. Ann Neurol 2018;84(6):946-9.** PMID 30383334
14: Eren OE, Ruscheweyh R, Rauschel V, Eggert T, Schankin CJ, Straube A. Magnetic suppression of perceptual accuracy is not reduced in visual snow syndrome. Front Neurol 2021a;12:658857. PMID 34017304
15: Eren OE, Ruscheweyh R, Straube A, Schankin CJ. Quantification of photophobia in visual snow syndrome: a case-control study. Cephalalgia 2020;40(4):393-8. PMID 31865761
16: Eren OE, Schöberl F, Schankin CJ, Straube A. Visual snow syndrome after start of citalopram-novel insights into underlying pathophysiology. Eur J Clin Pharmacol 2021b;77(2):271-2. PMID 32939564
17: Evers S, Holle-Lee D, Schankin CJ, Kull P, Raffaelli B. Visual snow syndrome is probably not mediated by CGRP: a case series. Cephalalgia 2022;42(11-12):1294-8. PMID 35614870
18: Foletta PJ, Clough M, McKendrick AM, Solly EJ, White OB, Fielding J. Delayed onset of inhibition of return in visual snow syndrome. Front Neurol 2021;12:738599. PMID 34603190
19: Graber M, Scutelnic A, Klein AM, Puledda F, Goadsby PJ, Schankin C. Natural course of visual snow syndrome: a long-term follow-up study. Brain Commun 2022;4(5):fcac230. PMID 36147453
20: Halpern JH, Pope HG Jr. Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend 2003;69(2):109-19. PMID 12609692
21: Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211. PMID 29368949
22: Hepschke JL, Seymour RA, He W, Etchell A, Sowman PF, Fraser CL. Cortical oscillatory dysrhythmias in visual snow syndrome: a magnetoencephalography study. Brain Commun 2021;4(1):fcab296. PMID 35169699
23: Jager HR, Giffin NJ, Goadsby PJ. Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 2005;25(5):323-32. PMID 15839846
24: Kinsbourne M, Warrington EK. A study of visual perseveration. J Neurol Neurosurg Psychiatry 1963;26:468-75. PMID 14066640
25: Klein A, Schankin CJ. Visual snow syndrome as a network disorder: a systematic review. Front Neurol 2021;12:724072. PMID 34671311
26: Kondziella D, Olsen MH, Dreier JP. Prevalence of visual snow syndrome in the UK. Eur J Neurol 2020;27(5):764-72. PMID 31999855
27: Lauschke JL, Plant GT, Fraser CL. Visual snow: a thalamocortical dysrhythmia of the visual pathway? J Clin Neurosci 2016;28:123-7. PMID 26791474
28: Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology 1995;45(4):664-8.** PMID 7723952
29: Luna S, Lai D, Harris A. Antagonistic relationship between VEP potentiation and gamma power in visual snow syndrome. Headache 2018;58(1):138-44. PMID 29193050
30: Mehta DG, Garza I, Robertson CE. Two hundred and forty-eight cases of visual snow: a review of potential inciting events and contributing comorbidities. Cephalalgia 2021;41(9):1015-26.** PMID 33615842
31: Michels L, Stämpfli P, Aldusary N, et al. Widespread white matter alterations in patients with visual snow syndrome. Front Neurol 2021;12:723805. PMID 34621237
32: Puledda F, Bruchhage M, O'Daly O, Ffytche D, Williams SCR, Goadsby PJ. Occipital cortex and cerebellum grey matter changes in visual snow syndrome. Neurology 2020c;95(13):e1792-9. PMID 32759201
33: Puledda F, Dipasquale O, Gooddy BJM, et al. Abnormal glutamatergic and serotonergic connectivity in visual snow syndrome and migraine with aura. Ann Neurol 2023;94(5):873-84. PMID 37466404
34: Puledda F, Ffytche D, Lythgoe D, et al. Insular and occipital changes in visual snow syndrome: a BOLD fMRI and MRS study. Ann Clin Transl Neurol 2020b;7(3):296-306. PMID 32154676
35: Puledda F, Ffytche D, O'Daly O, Goadsby PJ. Imaging the visual network in the migraine spectrum. Front Neurol 2019;10:1325. PMID 31920945
36: Puledda F, O'Daly O, Schankin C, Ffytche D, Williams SC, Goadsby PJ. Disrupted connectivity within visual, attentional and salience networks in the visual snow syndrome. Hum Brain Mapp 2021a;42(7):2032-44. PMID 33448525
37: Puledda F, Schankin C, Goadsby PJ. Visual snow syndrome: a clinical and phenotypical description of 1,100 cases. Neurology 2020a;94(6):e564-74.** PMID 31941797
38: Puledda F, Schankin C, Digre K, Goadsby PJ. Visual snow syndrome: what we know so far. Curr Opin Neurol 2017;31(1):52-8. PMID 29140814
39: Puledda F, Schankin CJ, O'Daly O, et al. Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study. J Neurol Neurosurg Psychiatry 2021b;92(9):918-26.** PMID 34261750
40: Puledda F, Vandenbussche N, Moreno-Ajona D, Eren O, Schankin C, Goadsby PJ. Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome. Br J Ophthalmol 2022a;106(9):1318-24. PMID 34656983
41: Puledda F, Villar-Martinez MD, Goadsby PJ. Case report: transformation of visual snow syndrome from episodic to chronic associated with acute cerebellar infarct. Front Neurol 2022b;13:811490. PMID 35242098
42: Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. 'Visual snow' - a disorder distinct from persistent migraine aura. Brain 2014;137(Pt 5):1419-28.** PMID 24645145
43: Schankin CJ, Maniyar FH, Chou DE, Eller M, Sprenger T, Goadsby PJ. Structural and functional footprint of visual snow syndrome. Brain 2020;143(4):1106-13.** PMID 32211752
44: Schankin CJ, Viana M, Goadsby PJ. Persistent and repetitive visual disturbances in migraine: a review. Headache 2017;57(1):1-16. PMID 27714802
45: Scutelnic A, Slavova N, Klein A, et al. Symptomatic visual snow in acute ischemic stroke: a case series. Headache 2023;63(1):173-6. PMID 36651600
46: Shibata M, Tsutsumi K, Iwabuchi Y, et al. [(123)I]-IMP single-photon emission computed tomography imaging in visual snow syndrome: a case series. Cephalalgia 2020;40(14):1671-5. PMID 32791921
47: Simpson JC, Goadsby PJ, Prabhakar P. Positive persistent visual symptoms (visual snow) presenting as a migraine variant in a 12-year-old girl. Pediatr Neurol 2013;49(5):361-3. PMID 23968568
48: Solly EJ, Clough M, McKendrick AM, Foletta P, White OB, Fielding J. Ocular motor measures of visual processing changes in visual snow syndrome. Neurology 2020;95(13):e1784-91. PMID 32675081
49: Solly EJ, Clough M, McKendrick AM, Foletta P, White OB, Fielding J. Eye movement characteristics provide an objective measure of visual processing changes in patients with visual snow syndrome. Sci Rep 2021;11(1):9607. PMID 33953220
50: Solly EJ, Clough M, McKendrick AM, White OB, Fielding J. Eye movement characteristics are not significantly influenced by psychiatric comorbidities in people with visual snow syndrome. Brain Res 2023;1804:148265. PMID 36709021
51: Strik M, Clough M, Solly EJ, et al. Brain network dynamics in people with visual snow syndrome. Hum Brain Mapp 2023;44(5):1868-75. PMID 36478470
52: Strik M, Clough M, Solly EJ, et al. Microstructure in patients with visual snow syndrome: an ultra-high field morphological and quantitative MRI study. Brain Commun 2022;4(4):fcac164. PMID 35974797
53: Thompson AC, Goodbourn PT, Forte JD. Perceived severity of visual snow syndrome is associated with visual allodynia. Headache 2023;63(4):494-505. PMID 36705299
54: Unal-Cevik I, Yildiz FG. Visual snow in migraine with aura: further characterization by brain imaging, electrophysiology, and treatment - case report. Headache 2015;55(10):1436-41. PMID 26307008
55: van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM. Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without. Eur J Neurol 2021;28(8):2631-8. PMID 33979006
56: van Dongen RM, Waaijer LC, Onderwater GLJ, Ferrari MD, Terwindt GM. Treatment effects and comorbid diseases in 58 patients with visual snow. Neurology 2019;93(4):e398-e403.** PMID 31213497
57: Viana M, Puledda F, Goadsby PJ. Visual snow syndrome: a comparison between an Italian and British population. Eur J Neurol 2020;27(10):2099-101. PMID 32478974
58: Wang YF, Fuh JL, Chen WT, Wang SJ. The visual aura rating scale as an outcome predictor for persistent visual aura without infarction. Cephalalgia 2008;28(12):1298-304. PMID 18727635
59: Yildiz FG, Turkyilmaz U, Unal-Cevik I. The clinical characteristics and neurophysiological assessments of the occipital cortex in visual snow syndrome with or without migraine. Headache 2019;59(4):484-94. PMID 30848479
60: Zaroban NJ, Kedar S, Anderson D, Vuppala AD. Analysis of retinal structure and electrophysiological function in visual snow syndrome: an exploratory case series. J Neuroophthalmol 2023;43(2):227-31. PMID 36503963

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Peter J Goadsby MD PhD FRS

Dr. Goadsby of King’s College London received consulting fees from Abbvie, Aeon Biopharma, Amgen, Eli Lilly, Epalex, Lundbeck, Novartis, Pfizer, Sanofi, Satsuma, Shiratronics, and Teva Neurosciences and a grant from Celegene.
See Profile
Francesca Puledda MD

Dr. Puledda of King’s College London received a consulting fee from Teva.
See Profile

Editor

Stephen D Silberstein MD

Dr. Silberstein, Director of the Jefferson Headache Center at Thomas Jefferson University has no relevant financial relationships to disclose.
See Profile

Patient Profile

Age range of presentation: 6 to 44 years
Sex preponderance: Female = male
Heredity: None
Population groups selectively affected: None
Occupation groups selectively affected: None

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Visual snow

Associated Disorders

Tinnitus
Migraine with and without aura

Differential Diagnosis

migraine aura
retinal pathologies
hallucinogen persisting perception disorder

Also Relevant

Migraine aura without headache
Migraine: clinical aspects
Objective tinnitus
Subjective tinnitus
Transient visual loss

Visual snow …

Visual snow

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Authors

Editor

Patient Profile

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Common maculopathies

Primary headache associated with sexual activity

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Primary cough headache

Medications and substances causing headache

Visual snow

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Authors

Editor

Patient Profile

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Common maculopathies

Primary headache associated with sexual activity

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Primary cough headache

Medications and substances causing headache

This is an article preview.
Start a Free Account
to access the full version.